SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): July 16, 2004
KIWA BIO-TECH PRODUCTS GROUP CORPORATION
(Exact Name of Registrant as Specified in Charter)
UTAH 000-33167 84-0448400
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
17700 CASTLETON STREET, SUITE 589
CITY OF INDUSTRY, CALIFORNIA 91748
(Address of Principal Executive Offices) (Zip Code)
(626) 964-3232
(Registrant's Telephone Number, Including Area Code)
ITEM 5. - OTHER EVENTS AND REGULATION FD DISCLOSURE
On July 16, 2004, Kiwa Bio-tech Products Group Corporation (the
"Registrant") issued a press release announcing that the Registrant had entered
into a Standby Equity Distribution Agreement ("Equity Agreement") with Cornell
Capital Partners, LP. Under the Equity Agreement, the Registrant may, at its
discretion, periodically issue and sell to Cornell Capital Partners common stock
for a total purchase price of up to $10,000,000. The Registrant agreed to
register the shares of common stock issuable under the Equity Agreement for
resale by Cornell Capital Partners prior to the first sale of such shares of
common stock. A copy of the press release is attached to this Form 8-K as
Exhibit 99.1 and is incorporated herein by reference.
ITEM 7. - FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Financial Statements of business acquired.
None.
(b) Pro forma Financial Information.
None.
(c) Exhibits.
99.1 Press release dated July 16, 2004, issued by the
Registrant.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
KIWA BIO-TECH PRODUCTS GROUP CORPORATION
Date: July 19, 2004 By: /S/ WEI LI
-----------------------------------------
Wei Li, Chief Executive Officer
3
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------- -----------
99.1 Press release dated July 16, 2004, issued by the Registrant.
4